Project Grant R01MD021301
- The National Institute for Minority Health and Health Disparities awarded Brown University $755,110 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a mixed-methods study examining the implications of Medicare Advantage enrollment growth on mortality and clinical outcomes among older adults in rural America. The research investigates how Medicare Advantage provider networks and reimbursement practices affect access to acute hospital...
- The National Institute for Minority Health and Health Disparities awarded Duke University $771,059 on August 5, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and test a tailored mHealth coaching and social resource support intervention designed to improve medication adherence and patient activation among kidney transplant recipients in low-resource communities. The project addresses health disparities in post-transplant outcomes, where...
- The National Institute for Minority Health and Health Disparities awarded the National Bureau of Economic Research Inc. $2,159,469 on September 3, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a Project Grant investigating the geographic distribution of dialysis facility expansion and its effects on health outcomes among patients with end-stage kidney disease. The research will analyze whether the 70 percent increase in dialysis centers over the...
- The National Institute for Minority Health and Health Disparities awarded the University of Washington $2.938 million on September 3, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds the ENRICH (Enhancing Kidney Care in Community Health Centers) project, a mixed-methods research initiative to improve kidney disease management in federally qualified health centers, rural health clinics, and other community-based providers serving high-risk...
- The National Institute for Minority Health and Health Disparities awarded The University of Chicago $1,307,468 on July 19, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to elucidate novel epigenetic contributions to multiple myeloma risk disparities between African American and European American populations. The research investigates cytosine modifications—specifically 5-hydroxymethylcytosines (5HMC)—in circulating cell-free DNA as drivers of the 2- to...
- The National Institute for Minority Health and Health Disparities awarded $208,555 to Trustees of Tufts College (doing business as Tufts University School of Medicine) on September 16, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds investigation of geographic, sociodemographic, and patient-specific differences in plant-based food consumption among U.S. youth, with the goal of identifying strategies to promote better nutrition and reduce...
- The National Institute for Minority Health and Health Disparities awarded The Rand Corporation $584,668 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct research on public health insurance and mortality among people with disabilities. The research will characterize all-cause and cause-specific mortality patterns among people with disabilities, examining variation by self-reported disability, SSA-defined primary impairment, race...
- The National Institute for Minority Health and Health Disparities awarded The University of Chicago $830,875 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to develop and evaluate a primary care model addressing interconception care—healthcare services provided after pregnancy to support optimal outcomes in future pregnancies. The award supports research on how primary care providers can address treatable chronic diseases including diabetes,...
- The National Institute for Minority Health and Health Disparities, National Institutes of Health, awarded Sojourn Medtech LLC $349,859 on September 17, 2025, to develop a patient-centered self-cannulation training simulator for African American patients with end-stage renal disease under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds development of a training tool designed to increase self-cannulation competency and promote home hemodialysis adoption...
- The National Institute for Minority Health and Health Disparities awarded Kaiser Foundation Hospitals (Kaiser Permanente) $10.492 million on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307). The award funds a mixed-methods implementation science study examining racial and ethnic disparities in depression treatment and outcomes across five health systems in seven states (California, Texas, Georgia, Minnesota, Michigan, North Dakota, and...
The National Institute for Minority Health and Health Disparities awarded Trustees of Indiana University (Indiana University Indianapolis) $833,155 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to assess how Medicare Advantage enrollment and plan characteristics intersect with patient and community factors to influence progress toward kidney transplantation among adults with end-stage kidney disease. The research uses an exploratory sequential mixed-methods design to examine transplant care pathway steps—referral, evaluation, and waitlisting—particularly among rural and socially vulnerable populations. Prior work by the research team documented that Medicare Advantage enrollees experience 18–24 percent lower transplant waitlisting rates than Traditional Medicare beneficiaries, yet the mechanisms through which Medicare Advantage enrollment affects earlier transplant care steps remain poorly understood. The award supports basic, clinical, social, and behavioral research to reduce health disparities and improve minority health outcomes. Performance occurs in Indianapolis, Indiana, with a period of performance from September 1, 2026, through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($3m) | 8/26/26 | ||
| Not listed | $3.9m | 8/25/26 |